Advances in Experimental Medicine and Biology - Gene and Cell Therapies for Beta-Globinopathies
Latest Publications

TOTAL DOCUMENTS

(FIVE YEARS 0)

H-INDEX

(FIVE YEARS 0)

Published By Springer New York

9781493972975, 9781493972999

Latest Documents Most Cited Documents Contributed Authors Related Sources Related Keywords

Current Standards of Care and Long Term Outcomes for Thalassemia and Sickle Cell Disease

Advances in Experimental Medicine and Biology - Gene and Cell Therapies for Beta-Globinopathies ◽

10.1007/978-1-4939-7299-9_3 ◽

2017 ◽

pp. 59-87 ◽

Cited By ~ 8

Author(s):

Satheesh Chonat ◽

Charles T. Quinn

Keyword(s):

Sickle Cell Disease ◽

Sickle Cell ◽

Standards Of Care ◽

Cell Disease ◽

Long Term Outcomes ◽

Current Standards

Download Full-text

Reactivation of Fetal Hemoglobin for Treating β-Thalassemia and Sickle Cell Disease

Advances in Experimental Medicine and Biology - Gene and Cell Therapies for Beta-Globinopathies ◽

10.1007/978-1-4939-7299-9_7 ◽

2017 ◽

pp. 177-202 ◽

Cited By ~ 5

Author(s):

Shuaiying Cui ◽

James Douglas Engel

Keyword(s):

Sickle Cell Disease ◽

Sickle Cell ◽

Fetal Hemoglobin ◽

Cell Disease

Download Full-text

Genetic Basis and Genetic Modifiers of β-Thalassemia and Sickle Cell Disease

Advances in Experimental Medicine and Biology - Gene and Cell Therapies for Beta-Globinopathies ◽

10.1007/978-1-4939-7299-9_2 ◽

2017 ◽

pp. 27-57 ◽

Cited By ~ 9

Author(s):

Swee Lay Thein

Keyword(s):

Sickle Cell Disease ◽

Sickle Cell ◽

Genetic Basis ◽

Genetic Modifiers ◽

Cell Disease

Download Full-text

Gene and Cell Therapy for β-Thalassemia and Sickle Cell Disease with Induced Pluripotent Stem Cells (iPSCs): The Next Frontier

Advances in Experimental Medicine and Biology - Gene and Cell Therapies for Beta-Globinopathies ◽

10.1007/978-1-4939-7299-9_9 ◽

2017 ◽

pp. 219-240 ◽

Cited By ~ 2

Author(s):

Eirini P. Papapetrou

Keyword(s):

Stem Cells ◽

Sickle Cell Disease ◽

Cell Therapy ◽

Induced Pluripotent Stem Cells ◽

Sickle Cell ◽

Pluripotent Stem Cells ◽

Cell Disease ◽

Induced Pluripotent ◽

Gene And Cell Therapy

Download Full-text

Gene Addition Strategies for β-Thalassemia and Sickle Cell Anemia

Advances in Experimental Medicine and Biology - Gene and Cell Therapies for Beta-Globinopathies ◽

10.1007/978-1-4939-7299-9_6 ◽

2017 ◽

pp. 155-176 ◽

Cited By ~ 6

Author(s):

Alisa C. Dong ◽

Stefano Rivella

Keyword(s):

Sickle Cell ◽

Sickle Cell Anemia

Download Full-text

Alternative Donor/Unrelated Donor Transplants for the β-Thalassemia and Sickle Cell Disease

Advances in Experimental Medicine and Biology - Gene and Cell Therapies for Beta-Globinopathies ◽

10.1007/978-1-4939-7299-9_5 ◽

2017 ◽

pp. 123-153 ◽

Cited By ~ 5

Author(s):

Courtney D. Fitzhugh ◽

Allistair Abraham ◽

Matthew M. Hsieh

Keyword(s):

Sickle Cell Disease ◽

Sickle Cell ◽

Unrelated Donor ◽

Cell Disease ◽

Alternative Donor

Download Full-text

Allogeneic/Matched Related Transplantation for β-Thalassemia and Sickle Cell Anemia

Advances in Experimental Medicine and Biology - Gene and Cell Therapies for Beta-Globinopathies ◽

10.1007/978-1-4939-7299-9_4 ◽

2017 ◽

pp. 89-122 ◽

Cited By ~ 5

Author(s):

Françoise Bernaudin ◽

Corinne Pondarré ◽

Claire Galambrun ◽

Isabelle Thuret

Keyword(s):

Sickle Cell ◽

Sickle Cell Anemia

Download Full-text

Genome Editing for the β-Hemoglobinopathies

Advances in Experimental Medicine and Biology - Gene and Cell Therapies for Beta-Globinopathies ◽

10.1007/978-1-4939-7299-9_8 ◽

2017 ◽

pp. 203-217 ◽

Cited By ~ 4

Author(s):

Matthew H. Porteus

Keyword(s):

Genome Editing

Download Full-text

Clinical Features of β-Thalassemia and Sickle Cell Disease

Advances in Experimental Medicine and Biology - Gene and Cell Therapies for Beta-Globinopathies ◽

10.1007/978-1-4939-7299-9_1 ◽

2017 ◽

pp. 1-26 ◽

Cited By ~ 3

Author(s):

Patrick T. McGann ◽

Alecia C. Nero ◽

Russell E. Ware

Keyword(s):

Sickle Cell Disease ◽

Clinical Features ◽

Sickle Cell ◽

Cell Disease

Download Full-text

Advances in Experimental Medicine and Biology - Gene and Cell Therapies for Beta-GlobinopathiesLatest Publications

TOTAL DOCUMENTS

H-INDEX

Published By Springer New York

Current Standards of Care and Long Term Outcomes for Thalassemia and Sickle Cell Disease

Reactivation of Fetal Hemoglobin for Treating β-Thalassemia and Sickle Cell Disease

Genetic Basis and Genetic Modifiers of β-Thalassemia and Sickle Cell Disease

Gene and Cell Therapy for β-Thalassemia and Sickle Cell Disease with Induced Pluripotent Stem Cells (iPSCs): The Next Frontier

Gene Addition Strategies for β-Thalassemia and Sickle Cell Anemia

Alternative Donor/Unrelated Donor Transplants for the β-Thalassemia and Sickle Cell Disease

Allogeneic/Matched Related Transplantation for β-Thalassemia and Sickle Cell Anemia

Genome Editing for the β-Hemoglobinopathies

Clinical Features of β-Thalassemia and Sickle Cell Disease

Advances in Experimental Medicine and Biology - Gene and Cell Therapies for Beta-Globinopathies
Latest Publications